Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

被引:134
|
作者
Foray, N
Randrianarison, V
Marot, D
Perricaudet, M
Lenoir, G
Feunteun, J
机构
[1] Inst Gustave Roussy, CNRS UMR 1599, Lab Genet Oncol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CNRS UMR 1582, Lab Vectorol & Transfert Genes, F-94805 Villejuif, France
[3] Univ Lyon 1, CNRS UMR 5641, Lab Genet & Canc, F-69365 Lyon, France
关键词
BRCA1; BRCA2; DNA repair; radiation;
D O I
10.1038/sj.onc.1203165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is now evidence to suggest that BRCA1 and BRCA2 are involved in the response of cells to DNA damage and cell cycle checkpoint control. This report examines the death pathways of human cells with various BRCA1 and BRCA2 genotypes after exposure to gamma-rays, A lack of functional BRCA1 and BRCA2 led to defective repair of DNA double-strand breaks in irradiated cells. This impairment resulted in a relaxation of cell cycle checkpoints, production of micronuclei, and a loss of proliferative capacity, Heterozygous BRCA1 and BRCA2 mutations also led to enhanced radiosensitivity, with an impaired proliferative capacity after irradiation. The existence of a phenotype related to radiosensitivity in BRCA1(+/-) and BRCA2(+/-) cells raises the question of the response of heterozygous women to radiation.
引用
收藏
页码:7334 / 7342
页数:9
相关论文
共 50 条
  • [1] Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2
    Nicolas Foray
    Voahangy Randrianarison
    Didier Marot
    Michel Perricaudet
    Gilbert Lenoir
    Jean Feunteun
    Oncogene, 1999, 18 : 7334 - 7342
  • [2] Screening for Genetic Mutations in BRCA1 and BRCA2
    Narod, Steven
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1365 - 1365
  • [3] Oophorectomy in women with BRCA1 or BRCA2 mutations
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
  • [4] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [5] BRCA1 and BRCA2 Mutations and Breast Cancer
    Narod, Steven A.
    Salmena, Leonardo
    DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
  • [6] Molecular Trajectory of BRCA1 and BRCA2 Mutations
    Hatano, Yuichiro
    Tamada, Maho
    Matsuo, Mikiko
    Hara, Akira
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Founder mutations in BRCA1 and BRCA2 genes
    Ferla, R.
    Calo, V.
    Cascio, S.
    Rinaldi, G.
    Badalamenti, G.
    Carreca, I.
    Surmacz, E.
    Coliucci, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 93 - 98
  • [8] BRCA1 and BRCA2 mutations and female fertility
    Smith, Ken R.
    Hanson, Heidi A.
    Hollingshaus, Michael S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (03) : 207 - 213
  • [9] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    CANCER RESEARCH, 2016, 76
  • [10] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    MODERN PATHOLOGY, 2019, 32